Table 1.
Frequency of typical Fabry disease complications in studied population
| Pediatric | Adults | |
|---|---|---|
| Gender (M/F) | 11/16 | 18/27 |
| Cornea verticillata (%) | 29.62% | 31.11% |
| Gastrointestinal discomfort (%) | 18.51% | 28.88% |
| Neuropathic pain (%) | 40.74% | 73.33% |
| Angiokeratomas (%) | 29.92% | 42.22% |
| Deafness (%) | 7.40% | 44.44% |
| LVH (%) | 0.00% | 44.445 |
| Arrhythmia (%) | 11.11% | 11.11% |
| CNS damage* (%) | 7.40% | 31.11% |
| Albuminuria/proteinuria (%) | 22.22% | 57.77% |
| eGFR decreased** (%) | 0.00% | 26.66% |
*Stroke and/or typical lesions in cerebral white substance in angionuclear magnetic resonance of brain. **eGFR <60 ml/min/m2. Ref: M: Males, F: Females, LVH: Left ventricular hypertrophy, CNS: Central nervous system, eGFR: Estimated glomerular filtration rate